IDStewardship

  • Home
  • Articles
  • LEARN ANTIBIOTICS
  • Study Guide
  • Resources
  • Q&A
  • #ASPchat
  • Contributors
  • About

How to become an infectious diseases pharmacist?



QUESTION

How to become an infectious diseases pharmacist?


ANSWER

There are a variety of ways to become an infectious diseases (ID) pharmacist. None of them are easy or quick. Three of the most common ways to qualify for an ID pharmacist job are briefly reviewed here…

  1. Complete a post-graduate year 2 infectious diseases pharmacy residency
    • Following pharmacy school pharmacists can complete post-graduate training. Doing a post-graduate year 1 (PGY1) pharmacy practice residency followed by a PGY2 ID pharmacy residency is one of the most common ways to qualify for ID pharmacist jobs. There are over 100 PGY2 ID pharmacy residencies in the United States. You can explore them via the ASHP online residency directory here.
  2. Complete an infectious diseases pharmacy fellowship
    • Pharmacy fellowships are usually 2 years in duration and it is fairly common for pharmacists to complete a PGY1 prior to fellowship. Fellowships are more academic and research-focused than residencies. There are only a handful of ID fellowships. You can explore them via the ACCP online fellowship directory here and via the SIDP ID fellowship listings page here. Fellowships are arguably the best way to become a pharmacy faculty member focused in ID.
  3. Clinical Practice Experience +/- a post-graduate year 1 pharmacy practice residency
    • With on the job experience a pharmacist can become an ID pharmacist. This is typically a long path of 5 or more years during which the pharmacist gains substantial pharmacy practice experience in the area of ID. Some pharmacists will complete PGY1 residencies that are focused in ID and that plus experience can be another path to qualify for an ID pharmacist job.

READINGS / RESOURCES

  • ASHP Pharmacy Residency Directory
  • ACCP Pharmacy Fellowships Directory
  • SIDP ID Pharmacy Fellowships Page
  • Reality Versus Expectation: Being a PGY2 ID Pharmacy Resident
  • Reality Versus Expectation: Completing an ID Pharmacy Fellowship
  • Reality Versus Expectation: Being an ID Pharmacist
  • Is a Pharmacy Residency or Fellowship Right for you?
  • Postgraduate Training and Career Opportunities in Infectious Diseases Pharmacy
  • Recommendations for Training and Certification for Pharmacists Practicing, Mentoring, and Educating in Infectious Diseases Pharmacotherapy

ANSWERED BY

Timothy P. Gauthier, Pharm.D., BCPS-AQ ID


Q&A DISCLAIMER

The ID PharmD Q&A pages attempt to answer common pharmacy questions by providing the perspective and opinion of a trained expert with substantial experience relevant to the question. That noted, these answers are not provided as all-inclusive comprehensive responses.


For more…


 

LEARN ANTIBIOTICS

Paperback Book

STEWARD PINS

Subscribe

Sign up for the monthly newsletter!

We will never spam you. We want you to like us. By clicking the Subscribe button, you accept the Terms of Service and Privacy Policy.

Categories

  • COVID-19
  • Healthcare At Large
  • Infectious Diseases & Antimicrobial Stewardship
  • Pharmacy News
  • Reality Check
  • Residency & Training
  • Facebook
  • Google+
  • Instagram
  • LinkedIn
  • Pinterest
  • Tumblr
  • Twitter
  • YouTube

Recent Posts

  • Best Infectious Diseases Articles From 2022 – A Year End Review Of Non-COVID Literature
  • The Learn Antibiotics Book
  • 2022 IDstewardship Year End Review
  • Antibiotics For Pediatric Respiratory Tract Infections In The Era Of Amoxicillin Shortages
  • What Does It Mean To Precept Responsibly & What Is The Precept Responsibly Podcast?

COVID-19

Musical Chairs & The ABCs of SARS-CoV-2 Monoclonal Antibodies

Musical Chairs & The ABCs of SARS-CoV-2 Monoclonal Antibodies

A Comparison Of Paxlovid Versus Molnupiravir: The First Oral COVID Antivirals

A Comparison Of Paxlovid Versus Molnupiravir: The First Oral COVID Antivirals

Five Things For Pharmacists To Know About The Omicron Variant

Five Things For Pharmacists To Know About The Omicron Variant

Molnupiravir – The New COVID Antiviral Named After Thor’s Hammer

Molnupiravir – The New COVID Antiviral Named After Thor’s Hammer

Tags

antibiotic Antibiotics antimicrobial stewardship bcps beta-lactam cancer Chemotherapy Clinical Controversies clinical pharmacist clinical pharmacy community pharmacist Critical Care emergency medicine Emoji Game fellowship figure1 Hepatitis C hospital pharmacist hospital pharmacy Infectious Disease infectious diseases Lifestyle MRSA NAPLEX Natural Disaster oncology pharmacist one-on-one penicillin allergy PGY2 Pharmacy Famous pharmacy fellowship Pharmacy Job pharmacy practice pharmacy residency pharmacy school pharmacy student Pharmacy technician PK-PD Compass Predatory Journals Rapid Diagnostic Testing social media student pharmacist study table transplant Zika

Penicillin Allergy Assessment Certificate Program

Recent

  • Best Infectious Diseases Articles From 2022 – A Year End Review Of Non-COVID Literature
  • The Learn Antibiotics Book
  • 2022 IDstewardship Year End Review
  • Antibiotics For Pediatric Respiratory Tract Infections In The Era Of Amoxicillin Shortages
  • What Does It Mean To Precept Responsibly & What Is The Precept Responsibly Podcast?

Search

Copyright 2016-2020 By Charlie Rose, LLC © · IDStewardship.com · Copyright · Privacy Policy · Terms · Contact